DIAGNOS (DGNOF) Stock Price, News & Analysis

Company Overview

DIAGNOS Inc. is a Canadian healthcare technology company focused on using artificial intelligence to support the early detection and screening of diseases. The company develops and deploys computer-assisted diagnostic tools designed to help healthcare professionals analyze medical images and identify potential health conditions.

Its primary technology platform, CARA, is used for the analysis of retinal images. DIAGNOS has applied the platform to screening for eye-related conditions, including diabetic retinopathy, and has also explored applications involving other diseases and medical imaging use cases. The company provides technology and screening services to healthcare providers, organizations and patients.

DIAGNOS has historically operated screening programs and pursued commercial relationships in Canada and international markets. Its business combines the development of artificial intelligence software with the delivery of diagnostic screening services, with an emphasis on expanding access to early detection in communities that may have limited access to specialized healthcare.

Key Stats

• Today's Range: $0.27 to $0.28
• 50-Day Range: $0.23 to $0.36
• 52-Week Range: $0.13 to $0.38
• Volume: 55,500 shs
• Average Volume: 115,853 shs
• Market Capitalization: $34.88 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 6/11/2026
• Today: 10/15/2026
• Next Earnings (Estimated): 12/01/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: OTCMKTS:DGNOF
• CIK: 1790693
• Web: www.diagnos.ca
• Phone: (450) 678-8882
• Fax: N/A
• Employees: 22
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.30 million
• Net Margins: -7,014.89%
• Pretax Margin: -6,956.72%
• Return on Equity: N/A
• Return on Assets: -192.10%

Debt

• Debt-to-Equity Ratio: 0.33
• Current Ratio: 1.49
• Quick Ratio: 1.49

Sales & Book Value

• Annual Sales: $50 thousand
• Price / Sales: 697.64
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 124,490,000
• Free Float: N/A
• Market Cap: $34.88 million
• Optionable: Not Optionable
• Beta: -0.02